Evidence-based Medicine and Equity: The Exclusion of Disadvantaged Groups

  • Wendy A. Rogers


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Biller-Andorno N, Lie R, Ter Meulen R (2002) Evidence based medicine as an instrument for rational health policy. Health Care Analysis 10:261–275CrossRefPubMedGoogle Scholar
  2. 2.
    Bleyer W, Tejeda H, Murphy S, Brawley O, Smith M, Ungerleider R (1997) Equal participation of minority patients in U.S. national pediatric cancer clinical trials. Journal of Pediatric Hematology Oncology 19: 423–427Google Scholar
  3. 3.
    Cookson R, McDaid D, Maynard A (2001) Wrong SIGN, NICE mess: is national guidance distorting allocation of resources? British Medical Journal 323:743–5PubMedGoogle Scholar
  4. 4.
    Dobson, F (1999) Secretary of State’s speech. http:// Scholar
  5. 5.
    Dresser R (1992) Wanted, Single white male. Hastings Center Report 22:24–29PubMedGoogle Scholar
  6. 6.
    Ebrahim S, Smith GD (1997) Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. British Medical Journal 314:1666–1674PubMedGoogle Scholar
  7. 7.
    Evelyn B, Toigo T, Banks D, Pohl D, Gray K, Robins B, Ernat J (2001) Participation of racial/ethnic groups in clinical trials and race-related labelling: a review of new molecular entities approved 1995-1999. Journal of the National Medical Association 93:18S–24SPubMedGoogle Scholar
  8. 8.
    European Secondary Prevention Study Group (1996) Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 347: 1203–1207Google Scholar
  9. 9.
    Giuliano A, Mokuau N, Hughes C, Tortolera-Luna G, Risendal B, Ho R, Prewitt T, McCaskill-Stevens W (2000) Participation of minorities in cancer research: the influence of structural, cultural and linguistic factors. Annals of Epidemiology 10:S22–S34CrossRefPubMedGoogle Scholar
  10. 10.
    Global Forum for Health Research (2002) The 10/90 report on health Research. Global Forum for Health Research, Geneva. Cited in: Horton R (2003) Medical journals: evidence of bias against the diseases of poverty. Lancet 361: 712–713Google Scholar
  11. 11.
    Hanley B, Truesdale A, King A, Elbourne D, Chalmers I (2001) Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. British Medical Journal 322: 519–523PubMedGoogle Scholar
  12. 12.
    Heiat A, Gross C, Krumholz H (2002) Representation of the elderly, women, and minorities in heart failure clinical trials. Archives of Internal Medicine 162:1682–1688CrossRefPubMedGoogle Scholar
  13. 13.
    Hooper L, Summerbell C, Higgins J, Thompson R, Capps N, Smith GD, Ebrahim S (2001) Dietary fat intake and prevention of cardiovascular disease: a systematic review. British Medical Journal 322:757–763PubMedGoogle Scholar
  14. 14.
    Horrobin D (2003) Are large clinical trials in rapidly lethal diseases usually unethical? Lancet 361:695–697CrossRefPubMedGoogle Scholar
  15. 15.
    Johnson J (2002) Influence of race or ethnicity on pharmacokinetics of drugs. Journal of Pharmaceutical Sciences 86:1328–1333Google Scholar
  16. 16.
    Kohl H (1995) Physical activity and cardiovascular disease: evidence for a dose response. Medicine and Science in Sports and Exercise 33: S472–S483Google Scholar
  17. 17.
    Matthews H (1995) Racial, ethnic and gender differences in response to medicines. Drug Metabolism & Drug Interactions 12:77–91Google Scholar
  18. 18.
    McAlister F, Taylor L, Teo K, Tsuyuki R, Ackman M, Yim R, Montague T (1999) The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? Journal of the American Geriatrics Society 47:811–818PubMedGoogle Scholar
  19. 19.
    Miller B, Koloel L, Bernstein L, Young J, Swanson G, West D, et al. (1996) Racial/ethnic patterns of cancer in the United States 1988-92. Bethesda, MD: National Cancer Institute, Bethesda. Cited in: Giuliano A et al. (2000) Participation of minorities in cancer research: the influence of structural, cultural and linguistic factors. Annals of Epidemiology 10: S22-S34Google Scholar
  20. 20.
    Moye LA, Powell JH (2001) Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered. Journal of the National Medical Association 93:29S–34SPubMedGoogle Scholar
  21. 21.
    Norheim OF (2002) The role of evidence in health policy making: a normative perspective. Health Care Analysis 10:309–317CrossRefPubMedGoogle Scholar
  22. 22.
    Owen W, Szczech L, Frankenfield D (2002) Health-care system interventions for inequality in quality: corrective action through Evidence-based Medicine. Journal of the National Medical Association 94:83S–91SPubMedGoogle Scholar
  23. 23.
    Raferty J (2001) NICE: faster access to modern treatments? Analysis of guidance on health technologies. British Medical Journal 323: 1300–1303Google Scholar
  24. 24.
    Rochon P, Clark J, Binns M, Patel V, Gurwitz J (1998) Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. Canadian Medical Association Journal 159:321–327PubMedGoogle Scholar
  25. 25.
    Rogers WA (2002) Evidence-based Medicine in practice: Limiting or facilitating patient choice? Health Expectations 5:95–103CrossRefPubMedGoogle Scholar
  26. 26.
    Sateren W, Trimble E, Brawley O, Breen N, Ford L, McCabe M, Ungerleider R, Christian M (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. Journal of Clinical Oncology 20:2109–2117CrossRefPubMedGoogle Scholar
  27. 27.
    Sherr L (2000) Women and clinical trials. In: Sherr L, St Lawrence J (Eds.) Women, health and the mind. John Wiley and Sons, Chichester, P 47–58Google Scholar
  28. 28.
    Starfield B (2001) New paradigms for quality in primary care. British Journal of General Practice 51:303–309PubMedGoogle Scholar
  29. 29.
    Sterne J, Egge M, Smith GD (2001) Investigating and dealing with publication and other biases in meta-analysis. British Medical Journal 323:101–105PubMedGoogle Scholar
  30. 30.
    Swanson GM, Bailar JC (2002) Selection and description of cancer clinical trials participants — science or happenstance? Cancer 95:950–959CrossRefPubMedGoogle Scholar
  31. 31.
    Taylor AL (2001) SERMs, ethnicity, and clinical trials: opportunities and challenges. Annals of the New York Academy of Sciences 949: 292–294PubMedGoogle Scholar
  32. 32.
    Watt G (2002) The inverse care law today. Lancet 360: 252–4CrossRefPubMedGoogle Scholar
  33. 33.
    Weissman N (2000) Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. New England Journal of Medicine 324:1094–1100Google Scholar
  34. 34.
    World Health Organisation (2002) The World Health Report 2002. World Health Organisation, GenevaGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Wendy A. Rogers

There are no affiliations available

Personalised recommendations